IgG4-related systemic diseases - Revision history

Michael: /* Microscopic */

2022-03-03T14:45:28Z

Microscopic

← Older revision		Revision as of 14:45, 3 March 2022
Line 18:		Line 18:
	Note:		Note:
	*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>
	** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>		** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mmmm and 3 HPFs (0.588 mmmm) are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>

	==Sign-out==		==Sign-out==

2022-03-03T14:44:34Z

← Older revision		Revision as of 14:44, 3 March 2022
Line 19:		Line 19:
	*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>
	** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>		** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>

			==Sign-out==
			===Not present===
			<pre>
			The provided clinical history is noted. Plasma cells are not readily apparent (<10 plasma cells/0.196 mm*mm).
			</pre>

	==See also==		==See also==

2022-03-03T14:41:45Z

2022-03-03T14:41:24Z

← Older revision		Revision as of 14:41, 3 March 2022
Line 19:		Line 19:
	*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>
	** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>		** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>

			==See also==
			*[[HPFitis]].

	==References==		==References==

2022-03-03T14:40:55Z

Microscopic

← Older revision		Revision as of 14:40, 3 March 2022
Line 18:		Line 18:
	Note:		Note:
	*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>
	** Lymph node: 100 plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are ~~examined~~.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>		** Lymph node: 100 (or 50) plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are assessed.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>

	==References==		==References==

2022-03-03T14:38:09Z

Microscopic

← Older revision		Revision as of 14:38, 3 March 2022
Line 18:		Line 18:
	Note:		Note:
	*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>
			** Lymph node: 100 plasma cells/HPF, where 1 HPF ~ 0.196 mm*mm and 3 HPFs are examined.<ref>{{cite journal \|authors=Cheuk W, Chan JK \|title=Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity \|journal=Semin Diagn Pathol \|volume=29 \|issue=4 \|pages=226–34 \|date=November 2012 \|pmid=23068302 \|doi=10.1053/j.semdp.2012.07.001 \|url=}}</ref>

	==References==		==References==

2022-02-17T21:34:36Z

Microscopic

← Older revision		Revision as of 21:34, 17 February 2022
Line 14:		Line 14:
	Features:<ref name=pmid28701054>{{cite journal \|authors=Abraham M, Khosroshahi A \|title=Diagnostic and treatment workup for IgG4-related disease \|journal=Expert Rev Clin Immunol \|volume=13 \|issue=9 \|pages=867–875 \|date=September 2017 \|pmid=28701054 \|pmc=5896560 \|doi=10.1080/1744666X.2017.1354698 \|url=}}</ref>		Features:<ref name=pmid28701054>{{cite journal \|authors=Abraham M, Khosroshahi A \|title=Diagnostic and treatment workup for IgG4-related disease \|journal=Expert Rev Clin Immunol \|volume=13 \|issue=9 \|pages=867–875 \|date=September 2017 \|pmid=28701054 \|pmc=5896560 \|doi=10.1080/1744666X.2017.1354698 \|url=}}</ref>
	*At least 10 IgG4 +ve plasma cells.†		*At least 10 IgG4 +ve plasma cells.†
	*>40% of plasma ~~cells~~ IgG4 +ve.		*>40% of [[plasma cell]]s IgG4 +ve.

	Note:		Note:

2022-02-17T21:34:25Z

Microscopic

← Older revision		Revision as of 21:34, 17 February 2022
Line 17:		Line 17:

	Note:		Note:
	*~~†Minimum~~ number dependent on anatomical site.<ref name=pmid28701054/>		*† Minimum number dependent on anatomical site.<ref name=pmid28701054/>

	==References==		==References==

2022-02-17T21:33:52Z

← Older revision		Revision as of 21:33, 17 February 2022
Line 17:		Line 17:

	Note:		Note:
	*		*†Minimum number dependent on anatomical site.<ref name=pmid28701054/>
	†Minimum number dependent on anatomical site.<ref name=pmid28701054/>

	==References==		==References==

2022-02-17T21:33:37Z

Microscopic

← Older revision		Revision as of 21:33, 17 February 2022
Line 17:		Line 17:

	Note:		Note:
			*
	†Minimum number dependent on anatomical site.<ref name=pmid28701054/>		†Minimum number dependent on anatomical site.<ref name=pmid28701054/>